CACLP - The largest IVD Expo & Conference

Technoclone Nabs FDA De Novo Authorization for ADAMTS13 Assay

Industry news | 07 March, 2024 | CACLP

Original from: 360dx

 

Diagnostic test maker Technoclone on Tuesday said it has secured US Food and Drug Administration de novo marketing authorization for a test that is used to aid the diagnosis of a rare, life-threatening blood-clotting disorder.

 

The Vienna-based firm said its Technozym ADAMTS13 Activity ELISA is used for the qualitative determination of von Willebrand factor-cleaving protease ADAMTS13 activity in platelet-poor citrated plasma. The results are used with other clinical and laboratory findings to aid in the diagnosis of thrombotic thrombocytopenic purpura in adult and pediatric patients who are being evaluated for the thrombotic microangiopathy group of rare disorders.

 

"In line with our commitment to provide ADAMTS13 diagnostics globally, we are excited about this milestone, having the first ADAMTS13 activity test granted with marketing authorization by the FDA," Technoclone CSO Nikolaus Binder said in a statement.

 

West Chester, Ohio-based DiaPharma Group will be the exclusive US distributor for the assay. DiaPharma is a seller of assay kits, reagents, and instrumentation for clinical and research applications related to bleeding and clotting disorders and liver injury.

 

Financial and other terms of the deal were not disclosed.

Source: Technoclone Nabs FDA De Novo Authorization for ADAMTS13 Assay

 

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference